{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:42:39Z","timestamp":1747186959152,"version":"3.40.5"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100008552","name":"Brigham Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["LUTS"],"published-print":{"date-parts":[[2023,11]]},"abstract":"Abstract<\/jats:title>Objectives<\/jats:title>Little is known about the impact of the COVID\u201019 pandemic on interstitial cystitis\/bladder pain syndrome (IC\/BPS). We aim to compare the number of newly diagnosed IC\/BPS cases and number of patients with flares prior to and during the pandemic.<\/jats:p><\/jats:sec>Methods<\/jats:title>We conducted a retrospective cohort study of women \u226518\u2009years who were diagnosed with or treated for IC\/BPS between March 2019 and March 2021 at an academic, urban, multisite urogynecology practice. The primary outcome was the number of IC\/BPS cases from March 1, 2019 to February 29, 2020 (pre\u2010pandemic) compared with March 1, 2020 to February 28, 2021 (during pandemic). The secondary outcome was the number of patients with flares during those same two time periods. Demographic and clinical characteristics were compared using nonparametric tests and interrupted time series (ITS) was used to evaluate our outcomes of interest. p<\/jats:italic>\u2010Value <.05 was considered significant.<\/jats:p><\/jats:sec>Results<\/jats:title>Fifty\u2010four women (4.87% of new patients) were diagnosed with IC\/BPS during the pandemic compared with 40 women pre\u2010pandemic (4.05% of new patients). The median age was 35.0. Seventy\u2010two percent were premenopausal, 75% sexually active, and 31% had anxiety, and there were no significant differences between groups. Although the number of patients newly diagnosed with IC\/BPS was higher during the pandemic, the diagnosis rates between time periods were not statistically different. Thirty\u2010five patients experienced flares during the pandemic compared with 49 patients the year prior (p<\/jats:italic>\u2009=\u2009.43). This difference was also not statistically significant on ITS analysis.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>Although more patients were diagnosed with IC\/BPS during versus before the pandemic, the difference in diagnosis rates was not different between these periods.<\/jats:p><\/jats:sec>","DOI":"10.1111\/luts.12502","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T05:31:22Z","timestamp":1694583082000},"page":"247-255","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Number of patients with interstitial cystitis\/bladder pain syndrome seen before versus during the COVID<\/scp>\u201019 pandemic at an academic, urban, multisite urogynecology practice"],"prefix":"10.1111","volume":"15","author":[{"given":"Tahireh","family":"Markert","sequence":"first","affiliation":[{"name":"Harvard Medical School Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-240X","authenticated-orcid":false,"given":"Alexa","family":"Courtepatte","sequence":"additional","affiliation":[{"name":"Division of Urogynecology Brigham and Women's Hospital Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subrina","family":"Farah","sequence":"additional","affiliation":[{"name":"Harvard Medical School Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannine M.","family":"Miranne","sequence":"additional","affiliation":[{"name":"Harvard Medical School Boston Massachusetts USA"},{"name":"Division of Urogynecology Brigham and Women's Hospital Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.01.086"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2014.05.004"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14399"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404\u2010017\u20104364\u20102"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192\u2010008\u20100573\u20103"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000146114.53828.82"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16096.1"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2019.01.012"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67152-2"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0090\u20104295(00)00988\u20102"},{"volume-title":"Stress and Decision\u2010Making during the Pandemic","year":"2021","author":"American Psychological Association","key":"e_1_2_9_12_1"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.08.001"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(21)02143\u20107"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255\u2010021\u201003030\u20102"},{"key":"e_1_2_9_16_1","unstructured":"Commonwealth of Massachusetts Office of Governor Charlie Baker and Lt. Governor Karyn Polito.Declaration of a State of Emergency to Respond to COVID\u201019 3\/10\/2020."},{"key":"e_1_2_9_17_1","unstructured":"Massachusetts' COVID\u201019 Vaccination Phases.Mass.gov Commonwealth of Massachusetts. Accessed May 10 2022.www.mass.gov\/info-details\/massachusetts-covid-19-vaccination-phases"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002756"},{"key":"e_1_2_9_19_1","unstructured":"SchwabL.FDA announces Elmiron drug safety\u2010related labeling changes. Drug Safety Developments. July 2 2020. Accessed September 29 2022.https:\/\/www.drug-injury.com\/drug_injury\/2020\/07\/fda-announces-elmiron-drug-safety-related-labeling-changes.html"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102736"}],"container-title":["LUTS: Lower Urinary Tract Symptoms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/luts.12502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T01:15:23Z","timestamp":1698974123000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/luts.12502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1111\/luts.12502"],"URL":"https:\/\/doi.org\/10.1111\/luts.12502","archive":["Portico"],"relation":{},"ISSN":["1757-5664","1757-5672"],"issn-type":[{"type":"print","value":"1757-5664"},{"type":"electronic","value":"1757-5672"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"2023-05-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}